JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 15 No. 6 436-438
© 1974 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, M. A.
Right arrow Articles by King, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, M. A.
Right arrow Articles by King, M. F.

Effects of Capillary Blockade with 99mTc-Iron Hydroxide: A Histopathologic Study

Michael A. Davis and Martin F. King

Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts

Correspondence: For reprints contact: M. A. Davis, Dept. of Radiology, Harvard Medical School, 50 Binney St., Boston, Mass. 02115.

ABSTRACT

Twenty-six mice injected with 99mTc-ferrous hydroxide macroaggregates (Tc-FHMA) were sequentially sacrificed over a 40-week period. Histologic sections of lung tissue stained for iron or with hematoxylin-eosin were prepared. Microscopic examination revealed changes in particle size and location of the FHMA with time after administration. Several mechanisms of clearance such as aggregate breakup, particle dissolution, and cellular phagocytosis were evident. The major finding was the complete absence of pathologic lesions that could be attributed to the long-term residence of Tc-FHMA in the pulmonary capillaries.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1974 by the Society of Nuclear Medicine.